Federal Register - February 10, 2021

Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.

Fuente: Federal Register

Federal Register / Vol. 86, No. 26 / Wednesday, February 10, 2021 / Notices The DG, entitled, Safety-Related Steel Structures and Steel-Plate Composite Walls for other than Reactor Vessels and Containments is a proposed new guide temporarily identified by its task number, DG1304.
It proposes guidance to meet regulatory requirements for safety-related steel structures and steel-plate composite walls for other than reactor vessels and containments. It endorses with, exceptions and clarifications, the 2018
edition of ANSI/AISC N6902018, Specification for Safety-Related Steel Structures for Nuclear Facilities.
The staff is also issuing for public comment a draft regulatory analysis ADAMS Accession No. ML20339A559.
The staff develops a regulatory analysis to assess the value of issuing or revising a regulatory guide as well as alternative courses of action.
III. Backfitting, Forward Fitting, and Issue Finality Issuance of DG1304, if finalized, would not constitute backfitting as that term is defined in title 10 of the Code of Federal Regulations 10 CFR section 50.109, Backfitting, and as described in NRC Management Directive 8.4, Management of Backfitting, Forward Fitting, Issue Finality, and Information Requests; constitute forward fitting as that term is defined and described in MD 8.4; or affect issue finality of any approval issued under 10 CFR part 52, Licenses, Certificates, and Approvals for Nuclear Power Plants. As explained in DG1304, applicants and licensees are not required to comply with the positions set forth in DG1361.
Dated: February 4, 2021.
For the Nuclear Regulatory Commission.
Meraj Rahimi, Chief, Regulatory Guidance and Generic Issues Branch, Division of Engineering, Office of Nuclear Regulatory Research.
FR Doc. 202102720 Filed 2921; 8:45 am BILLING CODE 759001P

NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission.
ACTION: Notice of meeting.
AGENCY:

The U.S. Nuclear Regulatory Commission NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes ACMUI
on March 16, 2021. A sample of agenda items to be discussed during the public session includes: An overview of fiscal
SUMMARY:

VerDate Sep<11>2014

18:53 Feb 09, 2021

Jkt 253001

year 2020 medical related events; a discussion on the status of the NRCs patient release evaluation of emerging brachytherapy sources; a discussion on calibration procedures for existing and emerging brachytherapy sources; a discussion on the current ACMUI
reporting structure; and an overview on the consequences of radiopharmaceutical extravasation and therapeutic interventions in nuclear medicine. The agenda is subject to change. The current agenda and any updates will be available on the ACMUIs Meetings and Related Documents web page at https
www.nrc.gov/reading-rm/doccollections/acmui/meetings/2021.html or by emailing Ms. Kellee Jamerson at the contact information below.
DATES: Date and Time for Open Session:
Tuesday, March 16, 2021, from 10:00
a.m. to 3:45 p.m. EST.
ADDRESSES:
Date March 16, 2021.

Webinar information Link: https
usnrc.webex.com.
Event number: 199 910
9533.

Public Participation: Due to the ongoing COVID19 public health emergency, the meeting will be held as a webinar using Cisco WebEx. Any member of the public who wishes to participate in any portion of this meeting should register in advance of the meeting by accessing the provided link above. Upon successful registration, a confirmation email will be generated providing the telephone bridge line and a link to join the webinar on the day of the meeting. Members of the public should also monitor the NRCs Public Meeting Schedule at https
www.nrc.gov/pmns/mtg for any meeting updates. If there are any questions regarding the meeting, persons should contact Ms. Jamerson using the information below.
FOR FURTHER INFORMATION CONTACT: Ms.
Kellee Jamerson, email:
Kellee.Jamerson@nrc.gov, telephone:
3014157408.
SUPPLEMENTARY INFORMATION:
Purpose: Discuss issues related to 10
CFR part 35 Medical Use of Byproduct Material.
Conduct of the Meeting The ACMUI Chair, Darlene F. Metter, M.D., will preside over the meeting. Dr.
Metter will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

8929

1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson using the contact information listed above. All submittals must be received by the close of business on March 10, 2021 and must only pertain to the topics on the agenda.
2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on ACMUIs website https www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2021.html on or about May 3, 2021.
4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Jamerson of their planned participation.
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended primarily Section 161a; the Federal Advisory Committee Act 5 U.S.C. App; and the Commissions regulations in Title 10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 4th day of February, 2021.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell, Federal Advisory Committee Management Officer.
FR Doc. 202102688 Filed 2921; 8:45 am BILLING CODE 759001P

OFFICE OF PERSONNEL
MANAGEMENT
Submission for Review: 32060156, Application for Death Benefits Under the Civil Service Retirement System SF 2800; Documentation in Support of Application for Death Benefits When Deceased Was an Employee at the Time of Death CSRS
Office of Personnel Management.
ACTION: 60-Day notice and request for comments.
AGENCY:

Retirement Services, Office of Personnel Management OPM offers the general public and other federal agencies the opportunity to comment on a renewal with minor edits of information collection request ICR, SF
2800Application for Death Benefits CSRS and SF 2800ADocumentation and Elections in Support of Application for Death Benefits When Deceased Was an Employee at the Time of Death CSRS. We have updated the way we display the OMB control number and there are editorial changes to the
SUMMARY:

E:FRFM10FEN1.SGM

10FEN1

Acerca de esta edición

Federal Register - February 10, 2021

TítuloFederal Register

PaísEstados Unidos de América

Fecha10/02/2021

Nro. de páginas155

Nro. de ediciones7801

Primera edición14/03/1936

Ultima edición24/06/2026

Descargar esta edición

Otras ediciones

<<<Febrero 2021>>>
DLMMJVS
123456
78910111213
14151617181920
21222324252627
28